Login to Your Account



Clinic Roundup


Thursday, February 28, 2013

• Inviragen Inc., of Fort Collins, Colo., said it started the second stage of its ongoing Phase II study testing DENVax, its dengue vaccine, following review and recommendation by the data safety monitoring board.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription